Skip to main content
Erschienen in: Journal of Neurology 10/2018

16.07.2018 | Original Communication

Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study

verfasst von: Marianna Amboni, Luigi Iuppariello, Alessandro Iavarone, Alfonso Fasano, Raffaele Palladino, Rosaria Rucco, Marina Picillo, Ilaria Lista, Pasquale Varriale, Carmine Vitale, Mario Cesarelli, Giuseppe Sorrentino, Paolo Barone

Erschienen in: Journal of Neurology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Cognition and gait appear to be closely related. The chronological interplay between cognitive decline and gait dysfunction is not fully understood. The aim of the present prospective study is investigating whether the dysfunction of specific gait parameters, during specific task and medication conditions, may predict subsequent cognitive impairment in Parkinson’s disease (PD). We evaluated cognition and gait in 39 Parkinsonian patients at an initial assessment and after 3 years. Cognitive performance was evaluated with a neuropsychological battery designed to assess memory, executive/attention, and visuospatial domains. Gait was investigated using a gait analysis system during both the off and on states in the following conditions: (1) normal gait; (2) motor dual task; and (3) cognitive dual task. We used regression models to determine whether gait predicts subsequent cognitive dysfunction. Overall, the cognitive test scores were stable over time with the exception of the executive/attention scores, whereas all gait parameters declined. The step length during the cognitive dual task during the on state at the initial evaluation was the only significant predictor of executive/attention domain dysfunction at follow up. The results were confirmed when executive/attention dysfunction at the initial assessment evaluation was included in the regression model as a covariate. Our longitudinal study offers additional insight into the progression of gait dysfunction, and its chronological relationship with cognitive dysfunction in PD patients. In particular, the present study indicates that step length during a cognitive task when on medication is an independent predictor of future executive/attention decline.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson’s disease. Mov Disord 26:2483–2495CrossRef Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson’s disease. Mov Disord 26:2483–2495CrossRef
2.
Zurück zum Zitat Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245CrossRef Muslimović D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245CrossRef
3.
Zurück zum Zitat Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease. Mov Disord 31:861–881CrossRef Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, Jiménez-Urbieta H, Rodriguez-Oroz MC (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson’s disease. Mov Disord 31:861–881CrossRef
4.
Zurück zum Zitat Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942CrossRef Aarsland D, Larsen JP, Tandberg E, Laake K (2000) Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc 48:938–942CrossRef
5.
Zurück zum Zitat Levy BR, Slade MD, Kunkel SR, Kasl SV (2002) Longevity increased by positive self-perceptions of aging. J Pers Soc Psychol 83:261CrossRef Levy BR, Slade MD, Kunkel SR, Kasl SV (2002) Longevity increased by positive self-perceptions of aging. J Pers Soc Psychol 83:261CrossRef
6.
Zurück zum Zitat Mollenhauer B, Rochester L, Chen-Plotkin A, Brooks D (2014) What can biomarkers tell us about cognition in Parkinson’s disease? Mov Disord 29:622–633CrossRef Mollenhauer B, Rochester L, Chen-Plotkin A, Brooks D (2014) What can biomarkers tell us about cognition in Parkinson’s disease? Mov Disord 29:622–633CrossRef
7.
Zurück zum Zitat Amboni M, Barone P, Hausdorff JM (2013) Cognitive contributions to gait and falls: evidence and implications. Mov Disord 28:1520–1533CrossRef Amboni M, Barone P, Hausdorff JM (2013) Cognitive contributions to gait and falls: evidence and implications. Mov Disord 28:1520–1533CrossRef
8.
Zurück zum Zitat Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J et al (2003) Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 18:884–889CrossRef Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J et al (2003) Extrapyramidal features in Parkinson’s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 18:884–889CrossRef
9.
Zurück zum Zitat Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006) Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord 21:1123–1130CrossRef Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D (2006) Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord 21:1123–1130CrossRef
10.
Zurück zum Zitat Uc E, Rizzo M, Anderson S, Qian S, Rodnitzky R, Dawson J (2005) Visual dysfunction in Parkinson disease without dementia. Neurology 65:1907–1913CrossRef Uc E, Rizzo M, Anderson S, Qian S, Rodnitzky R, Dawson J (2005) Visual dysfunction in Parkinson disease without dementia. Neurology 65:1907–1913CrossRef
11.
Zurück zum Zitat Domellöf ME, Elgh E, Forsgren L (2011) The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson’s disease. Mov Disord 26:2183–2189CrossRef Domellöf ME, Elgh E, Forsgren L (2011) The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson’s disease. Mov Disord 26:2183–2189CrossRef
12.
Zurück zum Zitat Amboni M, Barone P, Iuppariello L, Lista I, Tranfaglia R, Fasano A et al (2012) Gait patterns in Parkinsonian patients with or without mild cognitive impairment. Mov Disord 27:1536–1543CrossRef Amboni M, Barone P, Iuppariello L, Lista I, Tranfaglia R, Fasano A et al (2012) Gait patterns in Parkinsonian patients with or without mild cognitive impairment. Mov Disord 27:1536–1543CrossRef
13.
Zurück zum Zitat Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR (2016) Unmasking levodopa resistance in Parkinson’s disease. Mov Disord 31(11):1602–1609CrossRef Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR (2016) Unmasking levodopa resistance in Parkinson’s disease. Mov Disord 31(11):1602–1609CrossRef
14.
Zurück zum Zitat Verghese J, Wang C, Lipton RB, Holtzer R, Xue X (2007) Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 78:929–935CrossRef Verghese J, Wang C, Lipton RB, Holtzer R, Xue X (2007) Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 78:929–935CrossRef
15.
Zurück zum Zitat Mielke MM, Roberts RO, Savica R, Cha R, Drubach DI, Christianson T et al (2013) Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci 68:929–937CrossRef Mielke MM, Roberts RO, Savica R, Cha R, Drubach DI, Christianson T et al (2013) Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci 68:929–937CrossRef
16.
Zurück zum Zitat Morris R, Lord S, Bunce J, Burn D, Rochester L (2016) Gait and cognition: mapping the global and discrete relationships in ageing and neurodegenerative disease. Neurosci Biobehav Rev 64:326–345CrossRef Morris R, Lord S, Bunce J, Burn D, Rochester L (2016) Gait and cognition: mapping the global and discrete relationships in ageing and neurodegenerative disease. Neurosci Biobehav Rev 64:326–345CrossRef
17.
Zurück zum Zitat Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G et al (2017) Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease. Neurology 88(16):1501–1511CrossRef Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G et al (2017) Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease. Neurology 88(16):1501–1511CrossRef
18.
Zurück zum Zitat Morris R, Lord S, Lawson RA, Coleman S, Galna B, Duncan GW et al (2017) Gait rather than cognition predicts decline in specific cognitive domains in early Parkinson’s disease. J Gerontol A Biol Sci Med Sci 72(12):1656–1662CrossRef Morris R, Lord S, Lawson RA, Coleman S, Galna B, Duncan GW et al (2017) Gait rather than cognition predicts decline in specific cognitive domains in early Parkinson’s disease. J Gerontol A Biol Sci Med Sci 72(12):1656–1662CrossRef
19.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRef Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRef
20.
Zurück zum Zitat Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707CrossRef Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22(12):1689–1707CrossRef
21.
Zurück zum Zitat Caltagirone C, Gainotti G, Masullo C, Miceli G (1979) Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand 60:50–56CrossRef Caltagirone C, Gainotti G, Masullo C, Miceli G (1979) Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand 60:50–56CrossRef
22.
Zurück zum Zitat Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626CrossRef Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626CrossRef
23.
Zurück zum Zitat Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E (1998) A normative study on visual reaction times and two Stroop colour–word tests. Ital J Neurol Sci 19:161–170CrossRef Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E (1998) A normative study on visual reaction times and two Stroop colour–word tests. Ital J Neurol Sci 19:161–170CrossRef
24.
Zurück zum Zitat Manos PJ, Wu R (1994) The ten point clock test: a quick screen and grading method for cognitive impairment in medical and surgical patients. Int J Psychiatry Med 24:229–244CrossRef Manos PJ, Wu R (1994) The ten point clock test: a quick screen and grading method for cognitive impairment in medical and surgical patients. Int J Psychiatry Med 24:229–244CrossRef
25.
Zurück zum Zitat Spinnler H, Tognoni G (1987) Italian Group on the Neuropsychological Study of Ageing: Italian standardization and classification of neuropsychological tests. Ital J Neurol Sci 6:1–120 Spinnler H, Tognoni G (1987) Italian Group on the Neuropsychological Study of Ageing: Italian standardization and classification of neuropsychological tests. Ital J Neurol Sci 6:1–120
26.
Zurück zum Zitat Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRef Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRef
27.
Zurück zum Zitat Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J et al (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062–1069CrossRef Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J et al (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062–1069CrossRef
28.
Zurück zum Zitat Field A (2013) Discovering statistics using IBM SPSS statistics. Sage, London Field A (2013) Discovering statistics using IBM SPSS statistics. Sage, London
29.
Zurück zum Zitat Reinoso G, Allen JC Jr, Au WL, Seah SH, Tay KY, Tan LC (2015) Clinical evolution of Parkinson’s disease and prognostic factors affecting motor progression: 9-year follow-up study. Eur J Neurol 22:457–463CrossRef Reinoso G, Allen JC Jr, Au WL, Seah SH, Tay KY, Tan LC (2015) Clinical evolution of Parkinson’s disease and prognostic factors affecting motor progression: 9-year follow-up study. Eur J Neurol 22:457–463CrossRef
30.
Zurück zum Zitat Galna B, Lord S, Burn DJ, Rochester L (2015) Progression of gait dysfunction in incident Parkinson’s disease: impact of medication and phenotype. Mov Disord 30:359–367CrossRef Galna B, Lord S, Burn DJ, Rochester L (2015) Progression of gait dysfunction in incident Parkinson’s disease: impact of medication and phenotype. Mov Disord 30:359–367CrossRef
31.
Zurück zum Zitat Brown R, Marsden C (1990) Cognitive function in Parkinson’s disease: from description to theory. Trends Neurosci 13:21–29CrossRef Brown R, Marsden C (1990) Cognitive function in Parkinson’s disease: from description to theory. Trends Neurosci 13:21–29CrossRef
32.
Zurück zum Zitat Azuma T, Cruz RF, Bayles KA, Tomoeda CK, Montgomery EB (2003) A longitudinal study of neuropsychological change in individuals with Parkinson’s disease. Int J Geriatr Psychiatry 18:1115–1120CrossRef Azuma T, Cruz RF, Bayles KA, Tomoeda CK, Montgomery EB (2003) A longitudinal study of neuropsychological change in individuals with Parkinson’s disease. Int J Geriatr Psychiatry 18:1115–1120CrossRef
33.
Zurück zum Zitat Muslimović D, Post B, Speelman JD, De Haan RJ, Schmand B (2009) Cognitive decline in Parkinson’s disease: a prospective longitudinal study. J Int Neuropsychol Soc 15:426–437CrossRef Muslimović D, Post B, Speelman JD, De Haan RJ, Schmand B (2009) Cognitive decline in Parkinson’s disease: a prospective longitudinal study. J Int Neuropsychol Soc 15:426–437CrossRef
34.
Zurück zum Zitat Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE et al (2015) Longitudinal study of normal cognition in Parkinson disease. Neurology 85:1276–1282CrossRef Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE et al (2015) Longitudinal study of normal cognition in Parkinson disease. Neurology 85:1276–1282CrossRef
35.
Zurück zum Zitat Pedersen KF, Larsen JP, Tysnes O-B, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 70:580–586CrossRef Pedersen KF, Larsen JP, Tysnes O-B, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 70:580–586CrossRef
36.
Zurück zum Zitat Santangelo G, Vitale C, Picillo M, Moccia M, Cuoco S, Longo K et al (2015) Mild cognitive impairment in newly diagnosed Parkinson’s disease: a longitudinal prospective study. Parkinsonism Relat Disord 21:1219–1226CrossRef Santangelo G, Vitale C, Picillo M, Moccia M, Cuoco S, Longo K et al (2015) Mild cognitive impairment in newly diagnosed Parkinson’s disease: a longitudinal prospective study. Parkinsonism Relat Disord 21:1219–1226CrossRef
37.
Zurück zum Zitat Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH et al (2017) Stability of mild cognitive impairment in newly diagnosed Parkinson’s disease. J Neurol Neurosurg Psychiatry 88(8):648–652CrossRef Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH et al (2017) Stability of mild cognitive impairment in newly diagnosed Parkinson’s disease. J Neurol Neurosurg Psychiatry 88(8):648–652CrossRef
38.
Zurück zum Zitat Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W et al (2013) Measuring mild cognitive impairment in patients with Parkinson’s disease. Mov Disord 28:626–633CrossRef Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W et al (2013) Measuring mild cognitive impairment in patients with Parkinson’s disease. Mov Disord 28:626–633CrossRef
39.
Zurück zum Zitat Rochester L, Baker K, Nieuwboer A, Burn D (2011) Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson’s disease: Selective responses to internal and external cues. Mov Disord 26:430–435CrossRef Rochester L, Baker K, Nieuwboer A, Burn D (2011) Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson’s disease: Selective responses to internal and external cues. Mov Disord 26:430–435CrossRef
40.
Zurück zum Zitat Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB (2015) Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord 30:1361–1370CrossRef Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB (2015) Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord 30:1361–1370CrossRef
41.
Zurück zum Zitat Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B et al (2012) Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease. Brain 135:2779–2788CrossRef Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B et al (2012) Cholinergic dysfunction contributes to gait disturbance in early Parkinson’s disease. Brain 135:2779–2788CrossRef
42.
Zurück zum Zitat Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ et al (2013) Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology 81:1611–1616CrossRef Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ et al (2013) Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology 81:1611–1616CrossRef
43.
Zurück zum Zitat Blin O, Ferrandez A, Pailhous J, Serratrice G. Sci (1991) Dopa-sensitive and dopa-resistant gait parameters in Parkinson’s disease. J Neurol 103:51–54 Blin O, Ferrandez A, Pailhous J, Serratrice G. Sci (1991) Dopa-sensitive and dopa-resistant gait parameters in Parkinson’s disease. J Neurol 103:51–54
44.
Zurück zum Zitat Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM (2003) Gait dynamics in Parkinson’s disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 212:47–53CrossRef Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM (2003) Gait dynamics in Parkinson’s disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 212:47–53CrossRef
45.
Zurück zum Zitat Lord S, Howe T, Greenland J, Simpson L, Rochester L (2011) Gait variability in older adults: a structured review of testing protocol and clinimetric properties. Gait Posture 34:443–450CrossRef Lord S, Howe T, Greenland J, Simpson L, Rochester L (2011) Gait variability in older adults: a structured review of testing protocol and clinimetric properties. Gait Posture 34:443–450CrossRef
46.
Zurück zum Zitat Lord S, Galna B, Rochester L (2013) Moving forward on gait measurement: toward a more refined approach. Mov Disord 28(11):1534–1543CrossRef Lord S, Galna B, Rochester L (2013) Moving forward on gait measurement: toward a more refined approach. Mov Disord 28(11):1534–1543CrossRef
47.
Zurück zum Zitat Lord S, Galna B, Coleman S, Yarnall A, Burn D, Rochester L (2014) Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson’s disease. Front Aging Neurosci 6:249CrossRef Lord S, Galna B, Coleman S, Yarnall A, Burn D, Rochester L (2014) Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson’s disease. Front Aging Neurosci 6:249CrossRef
Metadaten
Titel
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study
verfasst von
Marianna Amboni
Luigi Iuppariello
Alessandro Iavarone
Alfonso Fasano
Raffaele Palladino
Rosaria Rucco
Marina Picillo
Ilaria Lista
Pasquale Varriale
Carmine Vitale
Mario Cesarelli
Giuseppe Sorrentino
Paolo Barone
Publikationsdatum
16.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8973-x

Weitere Artikel der Ausgabe 10/2018

Journal of Neurology 10/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.